|
MDM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.313800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.206400E-01 |
| Normal-vs-Stage2 |
1.848610E-01 |
| Normal-vs-Stage3 |
9.488000E-01 |
| Normal-vs-Stage4 |
4.313800E-01 |
| Stage1-vs-Stage2 |
3.881400E-01 |
| Stage1-vs-Stage3 |
2.252600E-01 |
| Stage1-vs-Stage4 |
6.138200E-01 |
| Stage2-vs-Stage3 |
1.793960E-01 |
| Stage2-vs-Stage4 |
9.986800E-01 |
| Stage3-vs-Stage4 |
4.214000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.284400E-02 |
| Normal-vs-AfricanAmerican |
8.546300E-02 |
| Normal-vs-Asian |
6.904800E-01 |
| Caucasian-vs-AfricanAmerican |
6.418400E-01 |
| Caucasian-vs-Asian |
4.055600E-01 |
| AfricanAmerican-vs-Asian |
3.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.394400E-02 |
| Normal-vs-Female |
8.551700E-02 |
| Male-vs-Female |
7.518600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.493620E-01 |
| Normal-vs-Extreme_Weight |
3.303800E-01 |
| Normal-vs-Obese |
8.820400E-02 |
| Normal-vs-Extreme_Obese |
4.960400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.396800E-01 |
| Normal_Weight-vs-Obese |
9.552400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.505400E-01 |
| Extreme_Weight-vs-Obese |
3.641400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.926400E-01 |
| Obese-vs-Extreme_Obese |
6.577000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.119980E-01 |
| Normal-vs-Age(41-60Yrs) |
4.924700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.449800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.568370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.548400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.585200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.886420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.038400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.756280E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.232780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.298600E-03 |
| Normal-VS-Type2 PRCC |
3.174800E-01 |
| Normal-VS-KIRP CIMP |
8.497000E-01 |
| Normal-VS-Unclassified PRCC |
1.407040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.210440E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.840600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.692200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.105600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.171600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.573400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.013400E-01 |
| Normal-vs-N1 |
1.808380E-01 |
| Normal-vs-N2 |
7.579400E-01 |
| N0-vs-N1 |
2.031400E-01 |
| N0-vs-N2 |
7.662800E-01 |
| N1-vs-N2 |
4.767600E-01 |
|
|
